Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

NGS

  • Open Access
    Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma
    VLASTIMIL KULDA, JIRI POLIVKA, MARTIN SVATON, TOMAS VANECEK, MARCELA BURESOVA, KATERINA HOUFKOVA, MAHYAR SHARIF BAGHERI, TEREZA KNIZKOVA, BOHUSLAVA VANKOVA, JINDRA WINDRICHOVA, PETR MACAN, VACLAV BABUSKA and MARTIN PESTA
    Cancer Genomics & Proteomics July 2023, 20 (4) 404-411; DOI: https://doi.org/10.21873/cgp.20392
  • Open Access
    Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome
    JAROSLAV JURACEK, MARIE MADRZYK, KAROLINA TRACHTOVA, MICHAELA RUCKOVA, JULIA BOHOSOVA, DOMINIK A. BARTH, MARTIN PICHLER, MICHAL STANIK and ONDREJ SLABY
    Cancer Genomics & Proteomics May 2023, 20 (3) 308-316; DOI: https://doi.org/10.21873/cgp.20383
  • You have access
    Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients
    GEORGIOS N. TSAOUSIS, EIRINI PAPADOPOULOU, KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, NIKOLAOS TSOULOS, IOANNIS BOUKOVINAS, THEOFANIS FLOROS, RODONIKI IOSIFIDOU, OURANIA KATOPODI, ANNA KOUMARIANOU, CHRISTOS MARKOPOULOS, KONSTANTINOS PAPAZISIS, VASILEIOS VENIZELOS, ACHILLEAS KAPSIMALIS, GRIGORIOS XEPAPADAKIS, AMANDA PSYRRI, EUGENIU BANU, DAN TUDOR ENIU, ALEXANDRU BLIDARU, DANA LUCIA STANCULEANU, ANDREI UNGUREANU, VAHIT OZMEN, SUALP TANSAN, MEHMET TEKINEL, SUAYIB YALCIN and GEORGE NASIOULAS
    Cancer Genomics & Proteomics January 2022, 19 (1) 60-78; DOI: https://doi.org/10.21873/cgp.20304
  • You have access
    Machine Learning Approaches on High Throughput NGS Data to Unveil Mechanisms of Function in Biology and Disease
    VASILEIOS C. PEZOULAS, ORSALIA HAZAPIS, NEFELI LAGOPATI, THEMIS P. EXARCHOS, ANDREAS V. GOULES, ATHANASIOS G. TZIOUFAS, DIMITRIOS I. FOTIADIS, IOANNIS G. STRATIS, ATHANASIOS N. YANNACOPOULOS and VASSILIS G. GORGOULIS
    Cancer Genomics & Proteomics September 2021, 18 (5) 605-626; DOI: https://doi.org/10.21873/cgp.20284
  • You have access
    MiR-139 Induces an Interferon-β Response in Prostate Cancer Cells by Binding to RIG-1
    ROBERT K. NAM, TANIA BENATAR, YUTAKA AMEMIYA and ARUN SETH
    Cancer Genomics & Proteomics May 2021, 18 (3) 197-206; DOI: https://doi.org/10.21873/cgp.20252
  • You have access
    Clinical Utility of Functional RNA Analysis for the Reclassification of Splicing Gene Variants in Hereditary Cancer
    KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, EIRINI PAPADOPOULOU, GEORGIOS N. TSAOUSIS, STAVROULA KAMPOURI, SONIA MARAVELAKI, ATHANASSIOS FASSAS, CHRISTOS CHRISTODOULOU, RODONIKI IOSIFIDOU, SOFIA KARAGEORGOPOULOU, CHRISTOS MARKOPOULOS, IOANNIS NATSIOPOULOS, KONSTANTINOS PAPAZISIS, MARIA VASILAKI-ANTONATOU, VASSILEIOS VENIZELOS, VAHIT OZMEN, SUALP TANSAN, KERIM KABAN, DAN TUDOR ENIU, ANGELICA CHIOREAN and GEORGE NASIOULAS
    Cancer Genomics & Proteomics May 2021, 18 (3) 285-294; DOI: https://doi.org/10.21873/cgp.20259
  • Open Access
    Tumor Mutational Patterns and Infiltrating Lymphocyte Density in Young and Elderly Patients With Breast Cancer
    ADAMANTIA NIKOLAIDI, VASSILIKI KOTOULA, GEORGIA-ANGELIKI KOLIOU, ELENI GIANNOULATOU, KYRIAKI PAPADOPOULOU, FLORA ZAGOURI, GEORGE PENTHEROUDAKIS, HELEN GOGAS, MATTHEOS BOBOS, KYRIAKOS CHATZOPOULOS, GEORGIOS OIKONOMOPOULOS, DIMITRIOS PECTASIDES, EMMANOUIL SALOUSTROS, NIKI ARNOGIANNAKI, IRENE NICOLAOU, PAVLOS PAPAKOSTAS, ILIADA BOMPOLAKI, GERASIMOS ARAVANTINOS, ILIAS ATHANASIADIS and GEORGE FOUNTZILAS
    Cancer Genomics & Proteomics March 2020, 17 (2) 181-193; DOI: https://doi.org/10.21873/cgp.20179
  • Open Access
    Pathogenic and Targetable Genetic Alterations in Resected Recurrent Undifferentiated Pleomorphic Sarcomas Identified by Targeted Next-generation Sequencing
    BIQIANG ZHENG, YUETING QU, JIAN WANG, YINGQIANG SHI and WANGJUN YAN
    Cancer Genomics & Proteomics May 2019, 16 (3) 221-228; DOI: https://doi.org/10.21873/cgp.20127
  • Open Access
    Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center Experience
    MOHAMMAD OMAR HUSSAINI, ABU-SAYEEF MIRZA, RAMI KOMROKJI, JEFFREY LANCET, ERIC PADRON and JINMING SONG
    Cancer Genomics & Proteomics March 2018, 15 (2) 121-126;
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire